Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Gurney
The 2016 Revised World Health Organization Definition of ‘Myelodysplastic Syndrome With Isolated Del(5q)’; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities
British Journal of Haematology
Hematology
Related publications
Impact of Clone Size With a Single Cytogenetic Abnormality on the Revised International Prognostic Scoring System in Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Cryptic 5q Deletion in a Patient With Myelodysplastic Syndrome
British Journal of Haematology
Hematology
Cytogenetic Prognostic Factors in Myelodysplastic Syndromes
Hematology & blood transfusion: interdepartamental collection
FISH and SNP-A Karyotyping in Myelodysplastic Syndromes: Improving Cytogenetic Detection of Del(5q), Monosomy 7, Del(7q), Trisomy 8 and Del(20q)
Leukemia Research
Cancer Research
Oncology
Hematology
Blood Consult: Treating Del(5q) Myelodysplastic Syndromes
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Unusual Clonal Evolution Involving 5q in a Case of Myelodysplastic Syndrome With Deletion 5q 31 Treated With Lenalidomide
Haematologica
Hematology
Accuracy of Clinical Diagnosis Versus the World Health Organization Case Definition in the Amoy Garden SARS Cohort
Canadian Journal of Emergency Medicine
Emergency Medicine
WHO-defined ‘Myelodysplastic Syndrome With Isolated Del(5q)’ in 88 Consecutive Patients: Survival Data, Leukemic Transformation Rates and Prevalence of JAK2, MPL and IDH Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Myelodysplastic Syndrome-Comorbidity Index Provides Additional Prognostic Information on Patients Stratified According to the Revised International Prognostic Scoring System
Haematologica
Hematology
